Reckitt Benckiser Group PLC

Synergy CHC Corp., the maker of Focus Factor, filed for Chapter 11 bankruptcy on September 4, 2026, in the U.S. Bankruptcy Court for the District of Columbia after Costco told the company in July it would discontinue Focus Factor products following a 16-year relationship. Costco accounted for approximately 58% of Synergy's net revenue in the fiscal year ended December 31, 2025, and its decision triggered an $18.9 million debt acceleration from the company's lender. Reckitt Benckiser, whose Neuriva brain supplement is already sold at Costco for $43.99 per 50-capsule bottle, is positioned as the clearest beneficiary, with H1 2026 Core Reckitt like-for-like net revenue growth of 2.7% accelerating to 4.2% in the second quarter, a 60.9% gross profit margin, a 24.8% adjusted operating profit margin, £419 million in first-half free cash flow, and roughly £3 billion returned to shareholders through dividends and buybacks. Reckitt also announced a 5% increase in its interim dividend and an additional £500 million share buyback, with full-year 2026 guidance calling for 4% to 5% like-for-like net revenue growth in Core Reckitt. RBGLY trades at $14.00, down 10.62% year-to-date, with a trailing P/E of 11.36 and a forward P/E of 14.24.

Reckitt Benckiser Group PLC announced a total dividend of $0.24 per share, with the ex-dividend date set for August 10, 2026, and payment on September 28, 2026. The company's trailing twelve-month dividend yield stands at 3.98%, while the forward yield is 3.95%. The dividend payout ratio is 0.62, indicating 62% of earnings are distributed, and GuruFocus ranks its profitability 7 out of 10. Over the past three years, the annual dividend growth rate was 5.70%, slowing to 3.60% over five years and 3.70% over ten years, while revenue and EPS growth have lagged behind many global peers.

The FTSE 100 set a new intraday record of 10,951.06 before closing up 0.3% at 10,908.41 on Wednesday, buoyed by strong earnings and rising oil prices. BP and Shell gained 3.4% and 2.8% respectively as Brent crude surged back above 90 dollars a barrel after President Trump vowed retaliation for an Iranian attack on US bases in Jordan. Among blue-chip stocks, Weir Group jumped 8.7% on robust first-half results, Sage Group rose 8.8% after an upbeat trading update, and Reckitt Benckiser added 4.3% as it announced a share buyback and reported second-quarter like-for-like sales growth of 4.7%, beating consensus. Standard Chartered climbed 2.9% after a record first-half performance and a 1 billion dollar buyback, while on the FTSE 250, Greggs soared 18% on half-year profit and sales that exceeded expectations. Attention now turns to the US Federal Reserve’s interest rate decision, with markets pricing a 34% chance of a hike amid limited forward guidance from new Fed chair Kevin Warsh.

The UK's FTSE 100 index rose 0.59% on Tuesday, driven by a strong rally in Unilever shares after the consumer goods giant reported better-than-expected earnings and raised its full-year guidance. The benchmark was up 63.90 points at 10,845.65 nearly half an hour past noon. Unilever climbed nearly 8% as it upgraded its full-year underlying sales growth guidance to the 4% to 6% range from its previous expectation of growth at the bottom end of the range, supported by around 3% underlying volume growth, and reported its best quarter of sales volume growth in 16 years. Other notable gainers included Admiral Group up over 4%, Relx up 3.6%, and Compass Group, Diageo, Imperial Brands, Croda International, Babcock International, Reckitt Benckiser, The Sage Group, and Experian climbing between 2.5% and 3%. Barclays Group shed more than 5% after reporting increased second-quarter operating costs, while Natwest Group and Lloyds Banking Group both eased about 1.3%. In economic news, UK shop price inflation rose 0.9% year-on-year in July 2026, missing expectations of 1.2% and marking the slowest increase since December 2025.